Life Sciences Venture Capital Investing Posts Gains in Q3

Venture capital funding in the life sciences sector, which includes the biotechnology and medical device industries, gained in Q3 in terms of dollars compared to the second quarter of 2012. But the sector still trended downward for the year, according to a new PwC US report that includes data from the PricewaterhouseCoopers, the National Venture Capital Association, and Thomson Reuters.

North AmericaUSBriefs